CStone Pharmaceuticals

2616.HK·HKSE·Healthcare
Compare
5.635+0.225 (+4.16%)today
At close: Nov 5, 4:08 PM HKT · May be delayed up to 15 min · HKD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close5.410
Open5.530
Day range5.4355.750
52-week range4.01010.410
Off day high−2.00%
Off 52-week high−45.87%
Volume12.20M
Avg. volume (3M)9.47M
Market cap8.98B
EPS (TTM)-0.3000
Forward P/E137.02
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.29
Shares outstanding1.59B
Short interest—
Earnings dateAug 27, 2026
Analyst target15.610
Profit margin−98.56%

Against its peers

Compare in full ›
2616.HK 9966.HK 688382.SS SMZ1.F 2171.HK 1167.HK
Market cap 8.98B 6.43B 8.38B 11.09B 6.48B 3.85B
P/E (TTM) — — — 31.2 — 6.6
Forward P/E 137.0 -21.0 -43.8 — 96.2 -167.5
Price/book 5.9 3.3 6.6 2.6 5.0 2.4
Dividend yield — — — 2.90% — —
1-year change −7.84% −39.84% −48.70% −23.60% −29.62% −32.34%
Today +4.16% +1.68% +4.33% +1.45% +3.36% +3.58%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All 2616.HK news ›
MarketScreener·Positive

CStone Pharmaceuticals Joins Stock Connect Southbound Trading

CStone Pharmaceuticals said its Hong Kong-listed shares have been added to the eligible securities list for southbound trading under Stock Connect, effective Sept. 7, according to a same-day Hong... CStone Pharmaceuticals Joins Stock…

MarketScreener·Positive

CStone Pharmaceuticals Drug Receives Ethics Approval in Australia

CStone Pharmaceuticals received ethics approval to begin clinical trials of its core candidate CS5007 in Australia, according to a Friday filing with the Hong Kong bourse. The firm plans to enroll... CStone Pharmaceuticals Drug Receives…

AZN

From the 4Search news index, newest first.

In the news

8mentions in 30 days
8with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance